Pre-clinical mechanism
Cell and animal studies describe inhibition of NF-κB signalling and reduced pro-inflammatory cytokine release in intestinal epithelial cells.
Key pre-clinical findings
- DSS-induced colitis mouse model: reduction in disease activity index and mucosal cytokine levels (Dalmasso et al., 2008).
Primary literature
Research and educational use only. This page summarises publicly available pre-clinical literature for educational and scientific reference. It is not medical, clinical, dosing or therapeutic advice. Nothing on this page implies that any VCP Australia product is approved, certified, safe, effective, suitable for a particular purpose, or intended for human or animal consumption.